{
    "Title": "Serious adverse events reported with benzimidazole derivatives: A disproportionality analysis from the World Health Organization’s pharmacovigilance database",
    "URL": "https://doi.org/10.1371/journal.pntd.0012634",
    "Published": "November 6, 2024",
    "Subject_Areas": [
        "Benzimidazoles",
        "Adverse events",
        "Drug safety",
        "Adverse reactions",
        "Anemia",
        "Bone marrow failure",
        "Hematology",
        "Medical risk factors"
    ],
    "Authors": {
        "Pamella Modingam": [
            "TransVIHMI, Université de Montpellier, INSERM Unité 1175, Institut de Recherche pour le Développement (IRD), Montpellier, France"
        ],
        "Jean-Luc Faillie": [
            "CHU Montpellier, Department of Medical Pharmacology and Toxicology, Montpellier, France",
            "Desbrest Institute of Epidemiology and Public Health, UMR UA11 University of Montpellier - INSERM, Montpellier, France"
        ],
        "Jérémy T. Campillo": [
            "TransVIHMI, Université de Montpellier, INSERM Unité 1175, Institut de Recherche pour le Développement (IRD), Montpellier, France"
        ]
    }
}